Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Roundup's label has a pesticide warning approved by the U.S. Environmental Protection Agency. The bill declares the existing label "sufficient to satisfy any requirement for a warning label regarding ...

The settlement with 15 states will resolve lawsuits alleging the drug OxyContin caused the opioid epidemic. ( Reuters) Bayer ...

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

The pharmaceutical landscape sees movement beyond the courtroom as Biogen focuses on growth from new product launches rather than acquisitions to drive future revenues. Similarly, Bayer's ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. For the quarter ended December ...

Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...

Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...